Még nem toboroz
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
NCT05038098· 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Naruhiko Ikoma
Még nem toboroz
PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma
NCT07511036· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Rodabe N Amaria, MD
Toboroz
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
NCT07377006· M.D. Anderson Cancer Center· Forrás
Contact: Debanjan Pain
Toboroz
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
NCT06769126· 2. fázis· SWOG Cancer Research Network· Forrás
Contact: Carl M. Gay (principal investigator)
Toboroz
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
NCT07216105· 1. fázis· Fate Therapeutics· Forrás
Contact: Principle Investigator
Toboroz
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
NCT07407920· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Vicente Valero, MD
Toboroz
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
NCT05873192· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Amado Zurita-Saavedra, MD
Toboroz
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
NCT04199026· M.D. Anderson Cancer Center· Forrás
Contact: Joseph A. Ludwig
Fut, nem toboroz
Comprehensive Assessment of Cancer Theranostic Response
NCT06815354· AIQ Solutions· Forrás
Toboroz
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
NCT06470243· 3. fázis· SWOG Cancer Research Network· Forrás
Contact: Paul Corn (principal investigator)
Toboroz
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
NCT06410209· 2. fázis· Children's Oncology Group· Forrás
Contact: Najat C. Daw (principal investigator)
Toboroz
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
NCT05041140· M.D. Anderson Cancer Center· Forrás
Contact: Ajay Sheshadri
Toboroz
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
NCT06022939· 3. fázis· SWOG Cancer Research Network· Forrás
Contact: Jing Christine Ye (principal investigator)
Fut, nem toboroz
The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer
NCT05961709· 2. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
NCT06066437· 1/2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Marisa Lozano
Toboroz
A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium
NCT05837039· M.D. Anderson Cancer Center· Forrás
Contact: Micheal Tang, MD
Toboroz
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
NCT06108232· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Dai Chihara, M D, PhD
Toboroz
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
NCT03594630· Korai 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: George J. Chang
Toboroz
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
NCT05231122· 2. fázis· Roswell Park Cancer Institute· Forrás
Contact: Amir A. Jazaeri
Fut, nem toboroz
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
NCT06113302· 2. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
NCT06105554· 1/2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Robert Orlowsky, M D
Toboroz
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
NCT05985954· 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Christine Parseghian, MD
Toboroz
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
NCT05967182· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Hop Tran Cao, MD
Fut, nem toboroz
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
NCT06053658· 2. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
NCT06045247· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Dai Chihara, M D
Toboroz
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
NCT05910801· 2. fázis· Academic and Community Cancer Research United· Forrás
Contact: Debbie Stroughter
Fut, nem toboroz
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
NCT05922904· 2. fázis· M.D. Anderson Cancer Center· Forrás
Fut, nem toboroz
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
NCT05722327· 1. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
NCT06085664· 1/2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Sumit K. Subudhi, MD, PHD
Toboroz
A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma
NCT05947838· M.D. Anderson Cancer Center· Forrás
Contact: Michael White, MD
Toboroz
Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
NCT06066359· 1/2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Muzaffar Qazilbash, M D
Toboroz
A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)
NCT06004336· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Chad Tang, MD
Toboroz
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
NCT06109870· M.D. Anderson Cancer Center· Forrás
Contact: Jane Montealegre, M. D.
Toboroz
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
NCT05834244· 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Abhishek Maiti, MD
Toboroz
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
NCT05902988· 1/2. fázis· Volastra Therapeutics, Inc.· Forrás
Contact: Ecaterina Dumbrava, MD
Toboroz
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
NCT05561387· 3. fázis· SWOG Cancer Research Network· Forrás
Contact: Jing Christine Ye (principal investigator)
Fut, nem toboroz
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
NCT05922930· 1/2. fázis· M.D. Anderson Cancer Center· Forrás
Fut, nem toboroz
A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
NCT05621668· 1. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
NCT06036810· M.D. Anderson Cancer Center· Forrás
Contact: Larissa Meyer, M D
Fut, nem toboroz
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer
NCT05761951· 2. fázis· M.D. Anderson Cancer Center· Forrás
Fut, nem toboroz
A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
NCT05704634· 1. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
NCT05776979· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Muzaffar Qazilbash, MD
Toboroz
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
NCT06006273· 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Fiorela Hernandez Tejada, MD
Fut, nem toboroz
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
NCT05836870· 3. fázis· M.D. Anderson Cancer Center· Forrás
Toboroz
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
NCT05819892· 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Pamela Soliman, MD
Toboroz
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
NCT05645718· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: David McCall, MD
Toboroz
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
NCT05636111· 1. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Shannon Westin, MD
Toboroz
3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
NCT05674396· 2. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Jay Reddy, MD, PHD
Fut, nem toboroz
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
NCT05672459· 1/2. fázis· M.D. Anderson Cancer Center· Forrás
Fut, nem toboroz
Reminder Messages for Lung Cancer Screening
NCT05952778· M.D. Anderson Cancer Center· Forrás
Showing 50 of 498.